Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Continuous venovenous hemodiafiltration versus standard medical therapy for the prevention of rhabdomyolysis-induced acute kidney injury: a retrospective cohort study

Fig. 2

Comparison of biochemical indicators between the CVVHDF + SMT group and SMT group at different time points. CVVHDF + SMT group, received continuous venovenous hemodiafiltration (CVVHDF) combined with standard medical therapy (SMT); SMT group, received SMT only. D0, before the first CVVHDF treatment; d2 and d7, 24 h and 7 days after the first CVVHDF treatment. Some patients received 1 or 2 more treatment(s) after the first treatment. Mb, myoglobin; CK, creatine kinase; Cr, creatinine; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; CO2-cp, carbon dioxide combining power; AG, anion gap

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us